The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Chiesi Farmaceutici S.p.A.EU/1/17/1208/004

Main Information

Trade NameTrimbow
Active SubstancesGlycopyrronium bromide
Formoterol fumarate dihydrate
Beclometasone dipropionate anhydrous
Dosage FormPressurised inhalation, solution
Licence HolderChiesi Farmaceutici S.p.A.
Licence NumberEU/1/17/1208/004

Group Information

ATC CodeR03AL Adrenergics in combination with anticholinergics
R03AL09 Formoterol, Glycopyrronium Bromide and Beclometasone


License statusAuthorised
Licence Issued17/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back